AnGes Inc (4563):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AnGes Inc (4563) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10137
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two projects under development, namely, a hepatocyte growth factor (HGF) plasmid, a genetic medicine that regenerates blood vessels improving blood circulation and NF-KB decoy oligonuvleotide. It also develops therapeutic vaccine projects including, Allovectin, a cancer treatment drug; and DNA and CIN (cervical intraepithelial neoplasia) therapeutic vaccines. AnGes is headquartered in Osaka, Japan.

AnGes Inc (4563) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AnGes Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AnGes Inc, Medical Devices Deals, 2012 to YTD 2018 9
AnGes Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AnGes Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Vasomune and AnGes Enter into Co-Development Agreement 11
Vical Enters into Co-Development Agreement with AnGes 12
AnGes MG Enters into Agreement with VIDO-InterVac 13
Vical Enters into Agreement with AnGes to Develop and Commercialize Equine Polyclonal Antibody Therapy 14
AnGes and Tella Enter into Agreement for Joint Research and Development of CIN Therapeutic Vaccine 15
AnGes MG Enters Into Co-Marketing Agreement With Mitsubishi Tanabe Pharma For Collategene 16
AnGes MG Enters into Agreement with Morishita Jintan 17
AnGes Enters Into Co-Development Agreement With BioLeaders For Hypertension Vaccine 18
Licensing Agreements 19
AnGes MG Enters into Licensing Agreement with Morishita Jintan 19
AnGes Enters into Licensing Agreement with Mitsubishi Tanabe Pharma 20
AnGes Exercises Option for Licensing Agreement with BioLeaders and GenoLac 21
Equity Offering 22
Vical Raises up to USD7.8 Million in Private Placement of Shares 22
AnGes MG Raises USD2.6 Million in Private Placement of Shares upon Exercise of Warrants 23
AnGes Announces Private Placement Of Shares For US$52 Million 24
AnGes Announces Private Placement Of Shares For US$2.5 Million 25
AnGes Inc – Key Competitors 26
AnGes Inc – Key Employees 27
AnGes Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Product Approvals 29
Mar 24, 2017: AnGes: Investigational New Drug (IND) Application Submitted to the FDA 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
AnGes Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AnGes Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AnGes Inc, Deals By Therapy Area, 2012 to YTD 2018 8
AnGes Inc, Medical Devices Deals, 2012 to YTD 2018 9
AnGes Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vasomune and AnGes Enter into Co-Development Agreement 11
Vical Enters into Co-Development Agreement with AnGes 12
AnGes MG Enters into Agreement with VIDO-InterVac 13
Vical Enters into Agreement with AnGes to Develop and Commercialize Equine Polyclonal Antibody Therapy 14
AnGes and Tella Enter into Agreement for Joint Research and Development of CIN Therapeutic Vaccine 15
AnGes MG Enters Into Co-Marketing Agreement With Mitsubishi Tanabe Pharma For Collategene 16
AnGes MG Enters into Agreement with Morishita Jintan 17
AnGes Enters Into Co-Development Agreement With BioLeaders For Hypertension Vaccine 18
AnGes MG Enters into Licensing Agreement with Morishita Jintan 19
AnGes Enters into Licensing Agreement with Mitsubishi Tanabe Pharma 20
AnGes Exercises Option for Licensing Agreement with BioLeaders and GenoLac 21
Vical Raises up to USD7.8 Million in Private Placement of Shares 22
AnGes MG Raises USD2.6 Million in Private Placement of Shares upon Exercise of Warrants 23
AnGes Announces Private Placement Of Shares For US$52 Million 24
AnGes Announces Private Placement Of Shares For US$2.5 Million 25
AnGes Inc, Key Competitors 26
AnGes Inc, Key Employees 27
AnGes Inc, Other Locations 28
AnGes Inc, Subsidiaries 28

List of Figures
AnGes Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AnGes Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AnGes Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AnGes Inc (4563):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HeartSciences:医療機器:M&Aディール及び事業提携情報
    Summary HeartSciences, formerly Heart Test Laboratories Inc, is a medical device company that offers cardiac care products. The company develops, manufactures and markets cardiac testing tools for the early detection of heart disease. It offers MyoVista, a screening tool used to determine the presen …
  • Tasly Pharmaceutical Group Co Ltd (600535):企業の財務・戦略的SWOT分析
    Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Surgical Care Affiliates LLC (SCAI)-医療機器分野:企業M&A・提携分析
    Summary Surgical Care Affiliates LLC (SCA) is a healthcare organization that offers patient care services. The organization's services include physician governance and engagement, scheduling optimization, staffing optimization, supply chain optimization, and case costing and profitability analysis. …
  • Solvay Specialty Polymers Italy SpA:企業の戦略的SWOT分析
    Solvay Specialty Polymers Italy SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析
    Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Premera Blue Cross:企業の戦略的SWOT分析
    Premera Blue Cross - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • OncoTherapy Science Inc (4564):医療機器:M&Aディール及び事業提携情報
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and d …
  • Metalico Inc:企業の戦略的SWOT分析
    Metalico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Bush Industries Inc:企業の戦略・SWOT・財務分析
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • WellSky Corp:企業の戦略的SWOT分析
    WellSky Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tessco Technologies Incorporated (TESS):企業の財務・戦略的SWOT分析
    Tessco Technologies Incorporated (TESS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Polaris Industries Inc (PII):企業の財務・戦略的SWOT分析
    Polaris Industries Inc (PII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Avesthagen Ltd-医療機器分野:企業M&A・提携分析
    Summary Avesthagen Ltd (Avesthagen) is a life science company that offers preventive personalized healthcare solutions. The company offers bio-nutrition, bio-agriculture and bio-pharmaceutical products. Its bio-nutrition products include validated bio-actives from Indian medicinal plants for prevent …
  • Intersect ENT Inc (XENT):企業の財務・戦略的SWOT分析
    Summary Intersect ENT Inc (Intersect), formerly Sinexus Inc is a medical device company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Intersect …
  • BoneSupport AB:医療機器:M&Aディール及び事業提携情報
    Summary BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; infect …
  • Puracap Pharmaceutical LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Puracap Pharmaceutical LLC (PuraCap) is a drug development company that offers prescription generics and OTC products. The company provides over the counter soft gels and oral solid dosage healthcare products for upper respiratory, pain relief, cough and cold, sleep aid, gastrointestinal, an …
  • Companhia Paranaense de Energia SA (CPLE6):企業の財務・戦略的SWOT分析
    Companhia Paranaense de Energia SA (CPLE6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • NicozDiamond Insurance Limited:企業の戦略・SWOT・財務分析
    NicozDiamond Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary NicozDiamond Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • The Tata Power Company Limited:企業の戦略・SWOT・財務分析
    The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Fiesta Mart LLC:企業の戦略的SWOT分析
    Fiesta Mart LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆